NASDAQ:CBIO | Cash Flow Statement | CRESCENT BIOPHARMA, INC.

Complete source-backed cash-flow history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$24.84M
2026-03-31-$23.28M-$8.94M$147,000.00-$8.15M-$6.95M
2025-12-31-$23.3M-$26.74M$193,000.00-$72.19M$178.86M
2025-09-30-$24.61M
2025-06-30-$21.79M
2025-03-31-$15.15M-$10.85M$0.00$0.00-$1.49M
2024-12-31-$7.22M-$3.7M$0.00$30,000.00$0.00
2024-09-30-$9.82M
2024-06-30-$10.1M
2024-03-31-$10.74M-$10.51M$7,439.00-$7,439.00$4,898.00
2023-12-31-$9.08M-$7.61M$801.00-$801.00$999.00
2023-09-30-$9.2M
2023-06-30-$8.26M
2023-03-31-$10.36M-$11.61M$2,197.00-$2,197.00$28.74M
2022-12-31-$10.24M-$7.91M$1.00-$1.00
2022-09-30-$8.52M
2022-06-30-$13.27M
2022-03-31-$14.65M-$13.7M$40,521.00-$40,521.00
2021-12-31-$17.42M-$12.81M$2,447.00-$2,447.00$1.14M
2021-09-30-$17.33M
2021-06-30-$14.4M
2021-03-31-$14.27M-$14.13M$3,060.00-$3,060.00$9.56M
2020-12-31-$15.56M-$9.69M$38,175.00-$38,175.00$3.89M
2020-09-30-$13.72M
2020-06-30-$14.08M
2020-03-31-$7.66M-$3.5M$8,136.00-$8,136.00$129,972.00
2019-12-31-$14.73M-$12.79M$12,357.00-$12,357.00$119,822.00
2019-09-30-$13.25M
2019-06-30-$15.83M
2019-03-31-$14.08M-$14.35M$39,538.00-$39,538.00$30,554.00
2018-12-31-$13.91M-$9.98M$57,004.00-$57,004.00$125,965.00
2018-09-30-$11.58M
2018-06-30-$11.28M
2018-03-31-$11.28M-$10.21M$16,618.00-$16,618.00$128.93M
2017-12-31-$9.26M-$8.37M$34,247.00-$34,247.00$19.46M
2017-09-30-$7.95M
2017-06-30-$8.14M
2017-03-31-$7.93M-$9.06M$62,969.00-$62,969.00$3.67M
2016-12-31-$8.33M-$5.95M$438,567.00-$438,567.00$1.15M
2016-09-30-$7.85M
2016-06-30-$8.07M
2016-03-31-$7.55M-$9.23M$17,270.00
2015-12-31-$8.88M-$6.96M$3,227.00
2015-09-30-$7.17M
2015-06-30$10.39M
2015-03-31-$7.11M-$8.71M$2,339.00
2014-12-31-$7.39M-$6.15M$14,865.00
2014-09-30-$6.62M
2014-06-30$7.99M
2014-03-31-$5.1M-$2.59M$13,920.00-$13,920.00$57.26M
2013-12-31-$3.87M-$5.57M$12,430.00
2013-09-30-$3.7M
2013-06-30-$3.5M
2013-03-31$459,687.00-$3.88M$6,824.00-$6,824.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$153.94M-$71.53M$919,000.00-$72.92M$322.98M
2024-12-31-$37.88M-$31.1M$9,972.00$20,028.00$5,398.00
2023-12-31-$36.9M-$34.88M$21,394.00-$21,394.00$28.82M
2022-12-31-$46.69M-$46.46M$84,191.00-$84,191.00$4.16M
2021-12-31-$63.43M-$57.49M$14,943.00-$14,943.00$10.72M
2020-12-31-$51.03M-$39.24M$68,507.00-$68,507.00$18.14M
2019-12-31-$57.89M-$51.98M$144,928.00-$144,928.00$412,913.00
2018-12-31-$48.27M-$43.33M$125,618.00-$125,618.00$129.45M
2017-12-31-$33.28M-$29.77M$294,107.00-$294,107.00$113.95M
2016-12-31-$31.81M-$29.73M$704,202.00-$704,202.00$23.67M
2015-12-31-$12.77M-$8.24M$268,594.00-$268,594.00$114,121.00
2014-12-31-$11.12M-$4.28M$212,603.00
2013-12-31-$10.61M-$15.54M$82,091.00
2012-12-31$3.66M-$10.47M$316,180.00